Spironolactone
Refractory/Recurrent Ascites
Post Graduate Institute of Medical Education and Research, ChandigarhSmall moleculePhase 2/3Dormant
B
61/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 46/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Refractory/Recurrent Ascites cohort.
Same molecule, other indications
Spironolactone is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →